Overall, these findings indicate that anti-Dsg1/3 antibodies trigger a signaling pathway culminating in pathogenic ADAM10 activation, whereas non-Dsg antibodies in PV induce blistering in an ADAM10-independent manner. The gene discussed is DSG1; the disease is acquired polycythemia vera.